In 2025, the medical field celebrated the approval of OncoRelief-25, a revolutionary anti-cancer medicine with minimal side effects. This cutting-edge treatment utilizes targeted therapy and AI-driven drug design to specifically attack cancer cells while sparing healthy tissues. OncoRelief-25 has shown exceptional results in treating various cancers, including lung, breast, and colon https://www.jasgurlifescience.com/oncology